Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial.
作者信息
Elomaa I, Blomqvist C, Rissanen P, Mäntylä M
机构信息
Department of Radiotherapy and Oncology, University of Helsinki, Finland.
出版信息
Acta Oncol. 1988;27(3):297-9. doi: 10.3109/02841868809093543.
PMID:2970862
Abstract
摘要
Zotero 插件